Investor

CDC Innovation

Last cheque observed Jun 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries DSeries C

Cheques on record
0%of best year0cheques in 12 months, 21 on record
Since the last cheque5254days00hrs00min00sec
Median round$6.2MRounds led0 of 21Sole investor1 roundsExits1 from the portfolioMostly inFrance, 81%
Pitch CDC Innovation

CDC Innovation highlights

  1. 01

    21 rounds on record

  2. 02

    Mostly Series B and Series D: 65% of its rounds

  3. 03

    Sole investor in 1 rounds, median $886K

  4. 04

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first21 appearances

  1. 2012

    1 round

  2. Jun
    Maeglin SoftwareFR · businesswire.comUndisclosedWith 1 other
  3. 2011

    1 round

  4. Jun
    Aldebaran RoboticsSeries C · FR · finsmes.com$13MWith 4 others
  5. 2010

    1 round

  6. Jun
    CytherisSeries D · FR · cytheris.com$15MWith 5 others
  7. 2009

    4 rounds

  8. May
    Radio Systemes IngenierieSeries D · FR$8.7MWith 3 others
  9. Apr
    AneviaSeries B · FR$6.6MWith 1 other
  10. Mar
    StantumSeries B · FR · venturebeat.com$16MWith 2 others
  11. Jan
    NovaledSeries C · DE · eetimes.eu$15MWith 7 others
  12. 2008

    2 rounds

  13. Oct
    cacaoTVSeed · FR$886KSole investor
  14. Oct
    Crocus TechnologySeries B · US · edageek.com$16MWith 5 others
  15. 2007

    3 rounds

  16. Nov
    Wirecom TechnologiesSeries B · FR$5.8MWith 4 others
  17. Feb
    Iwedia TechnologiesSeries D · FR · iwedia.com$5.2MWith 2 others
  18. Jan
    Aldebaran RoboticsSeries A · FR$7.3MWith 1 other
  19. 2006

    4 rounds

  20. Jul
    CitilogSeries D · FR$2.3MWith 1 other
  21. May
    NEMOPTICSeries D · FR$14MWith 9 others
  22. Mar
    Iwedia TechnologiesSeries C · FR$3.2MWith 1 other
  23. Jan
    Wirecom TechnologiesSeries A · FR$2.9MWith 2 others
  24. 2005

    5 rounds

  25. Dec
    NovaledSeries B · DE · novaled.com$18MWith 11 others
  26. Sept
    GraitecSeries C · FR · graitec.com$5.4MWith 1 other
  27. Jun
    Iwedia TechnologiesSeries B · FR$4.7MWith 2 others
  28. Jun
    IpracomSeries B · FR$2.5MWith 2 others
  29. Jan
    Kuros BiosurgerySeries B · CH · kuros.ch$5.4MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

NovaledBought by Samsung Electronics$347MAug 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as CDC Innovation. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about CDC Innovation

What does CDC Innovation invest in?

CDC Innovation invests most often at Series B and Series D (65% of the rounds on record).

How active is CDC Innovation?

21 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2012.

How big are CDC Innovation's cheques?

The median round it joins is $6.2M.

Does CDC Innovation lead rounds?

Rarely, if at all: none of its 21 investments on record names it as the lead.

Where does CDC Innovation invest?

Most of the companies it backs are in France (81%) and Germany (10%).

Is CDC Innovation investing now?

No investments in the last 12 months; the latest was in Jun 2012.

Who does CDC Innovation invest alongside?

Most often Crédit Agricole (5 rounds together), Omnes (5 rounds together) and I-Source Gestion (4 rounds together).

What kind of investor is CDC Innovation?

CDC Innovation is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it